The quick answerSince July 1, 2026, the Medicare GLP-1 Bridge pilot lets eligible beneficiaries get the Wegovy pill and injection, the Zepbound KwikPen and Foundayo for a flat $50 copay a month, unchanged as the dose rises, through December 31, 2027. Eligibility runs through clinical criteria and an approval step via your Part D plan. Medicare never covers compounded GLP-1s; if you don't qualify, the cash routes are brand-name ($149-$349 a month for Foundayo, $1,149+ for injections) or compounded ($49-$299).Prices verified on each provider’s site as of September 21, 2026.
What is the Medicare GLP-1 Bridge?
For years the rule was simple and frustrating: Medicare Part D could cover a GLP-1 prescribed for diabetes but not for weight loss. That changed in 2026.
The Centers for Medicare and Medicaid Services launched the Medicare GLP-1 Bridge, a pilot that began on July 1, 2026 and runs through December 31, 2027, under which eligible beneficiaries pay a flat $50 copay at the pharmacy for covered obesity medications. The $50 does not rise as the dose does, which is unusual: on cash prices, dose increases are where the cost climbs.
The name is literal - it is meant to bridge to a longer-term program that may or may not begin in 2028.
Our top 2 picks
Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.
Our Most Popular
1
Exceptional
9.8out of 10
Limited Offer - GLP-1 for $69/mon
Money-back guaranteeFree expedited delivery
Treatments offered
Compounded semaglutide injections (GLP-1) · Compounded tirzepatide injections (GLP-1 + GIP) · 100% online doctor review and prescription · Dosage adjustments through the patient portal
Starting price
$79$69/month
*Compounded medications are not FDA-approved.
- Compounded semaglutide ($69/mo) and tirzepatide ($119/mo)
- 5-minute health qualifier; doctor review usually within 24 hrs
- Free 1-2 day shipping - temperature-controlled, tracked, insured
- No insurance required, no clinic visits, cancel anytime
Pricing starts at
from $69/month
embody offers doctor-prescribed GLP-1 weight loss treatment - compounded semaglutide and tirzepatide injections - through a 100% online process. Getting started takes a roughly 5-minute health qualifier, after which a medical practitioner reviews your chart (embody says usually within 24 hours, often under 5). Pricing is flat and simple: $69/month for semaglutide and $119/month for tirzepatide, with no insurance required, no hidden fees, and no clinic visits. Medication ships in 1-2 days in temperature-controlled, tracked, insured packaging, and embody is LegitScript-certified and works with US-based 503A compounding pharmacies. On Trustpilot, embody averages 3.8 across 8,398 reviews - an honest, mixed-to-positive record whose recent reviews cluster around two themes: responsive, proactive customer service ('from my very first inquiry I've had excellent communication... customer service updated me every step,' writes one tirzepatide patient) and the no-surprises pricing ('Love the fact that there are no surprises as in costly up front cost'). A 3.7 also means a minority of customers had negative experiences - worth reading both ends of the reviews before deciding, as with any provider.
Read full embody review2
Exceptional
9.7out of 10
Most Comprehensive GLP-1 Medication Access
Transparent pricingNo insurance required
Treatments offered
Compounded semaglutide (GLP-1) injection · Compounded tirzepatide (GLP-1 + GIP) injection · Brand-name Zepbound and Wegovy · One simple injection per week
Starting price
$199$89/month
*Compounded medications are not FDA-approved.
- Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
- Brand-name options too: Zepbound and Wegovy
- Clinician-guided - physician, PA, or nurse practitioner
- Free shipping (about 5-7 days)
Pricing starts at
from $89/month
altRx bills itself as "the #1 most affordable GLP-1 program," and its published prices largely back that up: compounded GLP-1 (semaglutide) from $89/month and GLP-1 + GIP (tirzepatide) from $149/month - flat at every dose, so the price doesn't climb as you titrate up - alongside one of the few genuine brand-name shelves in this space (Ozempic $1,149, Zepbound $1,249, Wegovy $1,579 per month). It's a self-pay telehealth service: you complete a short assessment, a licensed provider (physician, PA, or nurse practitioner) reviews it, and if appropriate a prescription goes to a licensed US pharmacy, with free shipping in about 5-7 days. No insurance is required, Buy Now, Pay Later is available, and you can pause or cancel anytime. Two things to know before the details: shipping is slower than the 1-2 day providers (embody, DirectMeds), and Trustpilot does not currently display an aggregate score on altRx's profile - the individual reviews we quote on this page are real, but there's no independent average to lean on the way there is for rivals like Medvi (4.3 across 14,836) or embody (3.8 across 8,398). One of the real 4-star reviews we surface notes a refill 'yet to be fulfilled with zero reason as to why' - worth factoring in alongside the price advantage.
Read full altRx reviewWhich GLP-1 drugs does Medicare's Bridge cover?
Per the reporting on the program, the pilot covers the Wegovy pill and injection (semaglutide), the KwikPen formulation of Zepbound (tirzepatide) and Foundayo (orforglipron), Eli Lilly's daily pill approved in April 2026. Three things it does not cover: Ozempic or Mounjaro prescribed for weight loss (those are the diabetes labels of the same molecules), any compounded version of any of these - Medicare, like every insurer, does not pay for compounded GLP-1s - and, as far as we can verify, products outside that list. The differences between the brand drugs are in Zepbound vs Wegovy vs Ozempic; the pill-versus-injection choice in GLP-1 pills vs injections.
Who qualifies for the $50 copay, and what should you ask?
Coverage is not automatic. The program applies clinical criteria and requires approval before the $50 copay applies at the counter - the published reporting describes conditions around clinical guidelines and around what happens when the pilot ends.
We have not seen the full eligibility rules in a form we can verify, so we will not summarise them; the right sources are CMS's own program page and your Part D plan. Ask your plan three questions: am I eligible for the GLP-1 Bridge, which of the covered drugs are on your formulary under it, and what documentation does the approval need from my prescriber.
Ask your prescriber one: which of the covered drugs is right for me - a decision made on your history, not on price.
Shop GLP-1 plans by product
Every provider's published plans - cheapest first, conditions under each price.
What are the options if you don't qualify?
The cash market is the same one everyone else uses, and it has two tiers. Brand-name. Foundayo lists self-pay prices of $149 to $349 a month by dose through LillyDirect; brand injections run $1,149-$1,799 a month at the telehealth providers we track, detailed in what Zepbound costs online. Compounded. Semaglutide from $49 and tirzepatide from $89 a month at verified published prices, with the trade-offs - not FDA-approved, no trials of its own, never covered by insurance or Medicare - set out in compounded vs brand-name. What $100-$200 a month gets you sorts every option by what you keep paying.
What To Know Before Starting GLP-1 Treatment
Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.
GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.
That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.
What is different about GLP-1 treatment after 65?
Two things, both clinical. Weight lost on a GLP-1 includes lean mass as well as fat, and preserving muscle and bone matters more with age - which is a case for resistance exercise and adequate protein from the start, and for a clinician who tracks more than the scale.
And medication lists are longer at 65 than at 45, so interactions and existing conditions need a real review. GLP-1 weight loss over 40 and exercise on a GLP-1 cover both. For an older adult, a provider that offers a real clinician conversation and follow-up is worth more than the cheapest row in a price table - our provider-support comparison shows, from captured reviews, which providers actually answer.
The bottom line
If you are on Medicare and considering a GLP-1 for weight, ask your Part D plan about the GLP-1 Bridge before you price anything else: $50 a month for a brand-name, FDA-approved drug is the best number on this site, for as long as the pilot lasts. If you don't qualify, the cash options are the same as everyone's, and the month 1 vs year one page shows what each really costs.
Program rules and prices change; everything here is dated and we re-verify. A licensed clinician decides whether treatment is right for you - this page is about paying for it.